- 5.5Impact Factor
- 10.0CiteScore
- 15 daysTime to First Decision
Innovations in Ungual and Dermal Drug Delivery Systems for Localized Therapies
This special issue belongs to the section “Drug Delivery and Controlled Release“.
Special Issue Information
Dear Colleagues,
The topical treatment of ungual or dermal disorders is impaired by drugs’ physicochemical properties combined with the intrinsic characteristics of the nail plate and cutaneous barrier that lead to the poor permeation of drugs and/or bioactive molecules across its structure, consequentially making it difficult to achieve therapeutic concentrations on the diseased areas. This prompts an interest in developing nano-based systems, hydrogel-based formulations, 3D-printed pharmaceutical dosage forms, dressing films, other innovative systems and other strategies, for instance, microneedling, abrasive techniques, photodynamic therapy and the use of chemical penetration enhancers, as more effective alternatives for the topical treatment of ungual and skin conditions. Conditions such as psoriasis, atopic dermatitis, onycomycosis, wounds and fungal and bacterial infections may benefit from such localized therapies.
This Special Issue aims at gathering a selection of novel research in the area of innovations in ungual and dermal drug delivery, focused on the development of new formulations or methods for evaluating the in vitro and in vivo performance of localized therapies and strategies. Original research articles and reviews are welcome.
Prof. Dr. Letícia Scherer Koester
Dr. Helder Teixeira
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nano-based formulations
- hydrogel-based formulations
- 3D-printed formulations
- films
- biocompatibility
- ungual
- dermal
- in vitro release testing (IVRT)
- in vitro permeation testing (IVPT)
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

